Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Description

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

Conditions

Acute Decompensated Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Condition
Acute Decompensated Heart Failure
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosis of congestive acute decompensated heart failure (preserved or reduced ejection fraction) requiring clinically indicated IV diuresis
  • 2. Admission to coronary/cardiac intensive care unit or cardiac step down unit
  • 3. Able to provide written informed consent
  • 4. Anticipated need for IV diuretics \> 24 hrs
  • 1. Prisoner, pregnancy or post-partum stage, or age \< 18 years
  • 2. Known allergy to sensory material or gel
  • 3. End stage renal disease or need for CRRT
  • 4. Inability or contraindication to do a passive leg raise with both extremities (i.e., balloon pump, impella, spinal injury, amputation)
  • 5. Other situation that might increase subject risk, interfere with study procedures, or confound study findings based on the opinion of the clinician/investigator
  • 6. Inability to provide informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Carlos Alviar, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2025-07-01